Intermediate-term outcome of Aurolab aqueous drainage implant

PURPOSE: To report the intermediate-term safety and efficacy of Aurolab aqueous drainage implant (AADI) in patients with glaucoma. METHODS: Retrospective review of patients who underwent AADI between January 2013 and December 2016. Patients aged >16 years and with a minimum follow-up of 6 months...

Descripción completa

Detalles Bibliográficos
Autores principales: Philip, Reji, Chandran, Premanand, Aboobacker, Nabeed, Dhavalikar, Mrunali, Raman, Ganesh V
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376828/
https://www.ncbi.nlm.nih.gov/pubmed/30672476
http://dx.doi.org/10.4103/ijo.IJO_675_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376828/
https://www.ncbi.nlm.nih.gov/pubmed/30672476
http://dx.doi.org/10.4103/ijo.IJO_675_18

Ejemplares similares